Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DNA TOPOISOMERASE-I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 532 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Harayama, T; Akamatsu, H; Okamura, K; Miyagoe, T; Akiyama, T; Abe, H; Takeuchi, Y
      Synthesis of trisphaeridine and norchelerythrine through palladium-catalyzed aryl-aryl coupling reaction

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    2. Palumbo, M; Sissi, C; Gatto, B; Moro, S; Zagotto, G
      Quantitation of camptothecin and related compounds

      JOURNAL OF CHROMATOGRAPHY B
    3. Zufia, L; Aldaz, A; Giraldez, J
      Separation methods for camptothecin and related compounds

      JOURNAL OF CHROMATOGRAPHY B
    4. Balestrazzi, A; Bernacchia, G; Pitto, L; Luccarini, G; Carbonera, D
      Spatial expression of DNA topoisomerase I genes during cell proliferation in Daucus carota

      EUROPEAN JOURNAL OF HISTOCHEMISTRY
    5. Takebayashi, Y; Pourquier, P; Zimonjic, DB; Nakayama, K; Emmert, S; Ueda, T; Urasaki, Y; Kanzaki, A; Akiyama, S; Popescu, N; Kraemer, KH; Pommier, Y
      Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair

      NATURE MEDICINE
    6. Kirstein, MN; Houghton, PJ; Cheshire, PJ; Richmond, LB; Smith, AK; Hanna, SK; Stewart, CF
      Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts

      CLINICAL CANCER RESEARCH
    7. Minami, H; Fujii, H; Igarashi, T; Itoh, K; Tamanoi, K; Oguma, T; Sasaki, Y
      Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks

      CLINICAL CANCER RESEARCH
    8. Jagasia, MH; Langer, CJ; Johnson, DH; Yunus, F; Rodgers, JS; Schlabach, LL; Cohen, AG; Shyr, Y; Carbone, DP; DeVore, RF
      Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study

      CLINICAL CANCER RESEARCH
    9. Makinsky, AA; Kritzyn, AM; Ul'yanova, EA; Zakharova, OD; Bugreev, DV; Nevinsky, GA
      Polymethylene derivatives of nucleic bases with omega-functional groups: II. Adenine and hypoxanthine derivatives

      RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
    10. Shav-Tal, Y; Cohen, M; Lapter, S; Dye, B; Patton, JG; Vandekerckhove, J; Zipori, D
      Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changesin protein interactions

      MOLECULAR BIOLOGY OF THE CELL
    11. Dallavalle, S; Ferrari, A; Merlini, L; Penco, S; Carenini, N; De Cesare, M; Perego, P; Pratesi, G; Zunino, F
      Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    12. Guichard, S; Arnould, S; Hennebelle, I; Bugat, R; Canal, P
      Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo

      ANTI-CANCER DRUGS
    13. Cordell, GA; Quinn-Beattie, ML; Farnsworth, NR
      The potential of alkaloids in drug discovery

      PHYTOTHERAPY RESEARCH
    14. Sanz-Altamira, PM; O'Reilly, E; Stuart, KE; Raeburn, L; Steger, C; Kemeny, NE; Saltz, LB
      A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma

      ANNALS OF ONCOLOGY
    15. Rich, TA; Kirichenko, AV
      Camptothecin schedule and timing of administration with irradiation

      ONCOLOGY-NEW YORK
    16. Gonzalez, IL; Sylvester, JE
      Human rDNA: Evolutionary patterns within the genes and tandem arrays derived from multiple chromosomes

      GENOMICS
    17. Royce, ME; Hoff, PM; Dumas, P; Lassere, Y; Lee, JJ; Coyle, J; Ducharme, MP; De Jager, R; Pazdur, R
      Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): A novelcamptothecin analog

      JOURNAL OF CLINICAL ONCOLOGY
    18. Vanhoefer, U; Harstrick, A; Achterrath, W; Cao, SS; Seeber, S; Rustum, YM
      Irinotecan in the treatment of colorectal cancer: Clinical overview

      JOURNAL OF CLINICAL ONCOLOGY
    19. Socinski, MA; Sandler, AB; Miller, LL; Locker, PK; Hanover, CK; Elfring, GL; Israel, VK; Pirotta, N; Natale, RB
      Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    20. Fisher, BJ; Scott, C; Macdonald, DR; Coughlin, C; Curran, WJ
      Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507

      JOURNAL OF CLINICAL ONCOLOGY
    21. Biswas, A; Dey, J
      Ground and excited-state ionization behavior of 9-aminocamptothecin: An absorption and fluorescence spectral study

      INDIAN JOURNAL OF CHEMISTRY SECTION A-INORGANIC BIO-INORGANIC PHYSICAL THEORETICAL & ANALYTICAL CHEMISTRY
    22. Shigeoka, Y; Itoh, K; Igarashi, T; Ishizawa, K; Saeki, T; Fujii, H; Minami, H; Imoto, S; Sasaki, Y
      Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    23. Kim, Y; You, YJ; Ahn, BZ
      Naphthazarin derivatives (VIII): Synthesis, inhibitory effect on DNA topoisomerase-I, and antiproliferative activity of 6-(1-acyloxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones

      ARCHIV DER PHARMAZIE
    24. Bahadori, HR; Green, MR; Catapano, CV
      Synergistic interaction between topotecan and microtubule-interfering agents

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    25. Thomas, RR; Dahut, W; Harold, N; Grem, JL; Monahan, BP; Liang, M; Band, RA; Cottrell, J; Llorens, V; Smith, JA; Corse, W; Arbuck, SG; Wright, J; Chen, AP; Hamilton, JM; Allegra, CJ; Takimoto, CH
      A phase I and pharmacologic study of 9-aminocamptothecin administered as a120-h infusion weekly to adult cancer patients

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    26. Kang, SH; Park, MH; Song, EY; Kang, SJ; Lee, EB; Song, YW; Takeuchi, F
      Association of HLA class II genes with systemic sclerosis in Koreans

      JOURNAL OF RHEUMATOLOGY
    27. Kim, SH; Kang, IC; Yoon, TJ; Park, YM; Kang, KS; Song, GY; Ahn, BZ
      Antitumor activities of a newly synthesized shikonin derivative, 2-hyim-DMNQ-S-33

      CANCER LETTERS
    28. Allemand, E; Gattoni, R; Bourbon, HM; Stevenin, J; Caceres, JF; Soret, J; Tazi, J
      Distinctive features of Drosophila alternative splicing factor RS domain: Implication for specific phosphorylation, shuttling, and splicing activation

      MOLECULAR AND CELLULAR BIOLOGY
    29. Topcu, Z
      DNA topoisomerases as targets for anticancer drugs

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    30. Song, GY; Kim, Y; You, YJ; Cho, H; Ahn, BZ
      Naphthazarin derivatives (VII): Antitumor action against ICR mise bearing ascitic S-180 cells

      ARCHIVES OF PHARMACAL RESEARCH
    31. Song, GY; Kim, Y; You, YJ; Cho, H; Ahn, BZ
      Naphthazarin derivatives (VII): Antitumor action against ICR mice bearing ascitic S-180 cells

      ARCHIVES OF PHARMACAL RESEARCH
    32. Sidorik, LL; Todurov, IM; Vigontina, OG; Rybkinska, TA; Vudmaska, MI; Naydenov, VG; Kopchak, VM; Matsuka, GC
      Antibodies against DNA topoisomerase I in blood serum of patients with pathologies of pancreas

      EXPERIMENTAL ONCOLOGY
    33. Turker, L
      A theoretical study on camptothecin-AM1 treatment

      JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
    34. Grivicich, I; Mans, DRA; Peters, GJ; Schwartsmann, G
      Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    35. Zhang, XB; Kiechle, F
      Hoechst 33342-induced apoptosis is associated with decreased immunoreactive topoisomerase I and topoisomerase I-DNA complex formation

      ANNALS OF CLINICAL AND LABORATORY SCIENCE
    36. Dumas, C; Royer, J; Husson, HP
      Partial synthesis of camptothecin analogs. Part 3: Easy approach to a quinoline-lactone system

      TETRAHEDRON LETTERS
    37. Harayama, T; Akiyama, T; Akamatsu, H; Kawano, K; Abe, H; Takeuchi, Y
      Total synthesis of benzo[c]phenanthridine alkaloids, chelerythrine and 12-methoxydihydrochelerythrine, by a palladium-assisted internal biaryl coupling reaction

      SYNTHESIS-STUTTGART
    38. Strel'tsov, SA; Grokhovskii, SL; Kudelina, IA; Oleinikov, VA; Zhuze, AL
      Interaction of topotecan, DNA tapoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. 1. Topotecan dimerization in solution

      MOLECULAR BIOLOGY
    39. Fan, Y; Shi, LM; Kohn, KW; Pommier, Y; Weinstein, JN
      Quantitative structure-antitumor activity relationships of camptothecin analogues: Cluster analysis and genetic algorithm-based studies

      JOURNAL OF MEDICINAL CHEMISTRY
    40. Dallavalle, S; Ferrari, A; Biasotti, B; Merlini, L; Penco, S; Gallo, G; Marzi, M; Tinti, MO; Martinelli, R; Pisano, C; Carminati, P; Carenini, N; Beretta, G; Perego, P; De Cesare, M; Pratesi, G; Zunino, F
      Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity

      JOURNAL OF MEDICINAL CHEMISTRY
    41. Kim, DK; Ryu, DH; Lee, JY; Lee, N; Kim, YW; Kim, JS; Chang, K; Im, GJ; Kim, TK; Choi, WS
      Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues

      JOURNAL OF MEDICINAL CHEMISTRY
    42. Kuwana, M; Okano, T; Ogawa, Y; Kaburaki, J; Kawakami, Y
      Autoantibodies to the amino-terminal fragment of beta-fodrin expressed in glandular epithelial cells in patients with Sjogren's syndrome

      JOURNAL OF IMMUNOLOGY
    43. Zhou, XD; Tan, FK; Xiong, MM; Milewicz, DM; Feghali, CA; Fritzler, MJ; Reveille, JD; Arnett, FC
      Systemic sclerosis (scleroderma): Specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts

      JOURNAL OF IMMUNOLOGY
    44. Kuwana, M; Kaburaki, J; Wright, TM; Kawakami, Y; Ikeda, Y
      Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors

      EUROPEAN JOURNAL OF IMMUNOLOGY
    45. Larsen, AK; Gilbert, C; Chyzak, G; Plisov, SY; Naguibneva, I; Lavergne, O; Lesueur-Ginot, L; Bigg, DCH
      Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells

      CANCER RESEARCH
    46. Erlichman, C; Boerner, SA; Hallgren, CG; Spieker, R; Wang, XY; James, CD; Scheffer, GL; Maliepaard, M; Ross, DD; Bible, KC; Kaufmann, SH
      The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistanceprotein-mediated drug efflux

      CANCER RESEARCH
    47. De Cesare, M; Pratesi, G; Perego, P; Carenini, N; Tinelli, S; Merlini, L; Penco, S; Pisano, C; Bucci, F; Vesci, L; Pace, S; Capocasa, F; Carminati, P; Zunino, F
      Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin

      CANCER RESEARCH
    48. Pilch, B; Allemand, E; Facompre, M; Bailly, C; Riou, JF; Soret, J; Tazi, J
      Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506

      CANCER RESEARCH
    49. Tsai, TH; Lee, CH; Yeh, PH
      Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis

      BRITISH JOURNAL OF PHARMACOLOGY
    50. Arai, T; Yoshida, K; Kaburaki, J; Inoko, H; Ikeda, Y; Kawakami, Y; Kuwana, M
      Autoreactive CD4(+) T-cell clones to beta 2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site

      BLOOD
    51. Kuwana, M; Kaburaki, J; Kitasato, H; Kato, M; Kawai, S; Kawakami, Y; Ikeda, Y
      Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura

      BLOOD
    52. Brehm, BR; Bock, C; Wesselborg, S; Pfeiffer, S; Schuler, S; Schulz-Osthoff, K
      Prevention of human smooth muscle cell proliferation without induction of apoptosis by the topoisomerase I inhibitor topotecan

      BIOCHEMICAL PHARMACOLOGY
    53. Borioli, GA; Caputto, BL; Maggio, B
      c-Fos is surface active and interacts differentially with phospholipid monolayers

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    54. Hochberg, F; Grossman, SA; Mikkelsen, T; Glantz, M; Fisher, JD; Piantadosi, S
      Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma

      NEURO-ONCOLOGY
    55. Utz, PJ; Gensler, TJ; Anderson, P
      Death, autoantigen modifications, and tolerance

      ARTHRITIS RESEARCH
    56. Carmo-Fonseca, M; Mendes-Soares, L; Campos, I
      To be or not to be in the nucleolus

      NATURE CELL BIOLOGY
    57. Escoriaza, J; Aldaz, A; Castellanos, C; Calvo, E; Giraldez, J
      Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies

      JOURNAL OF CHROMATOGRAPHY B
    58. Pichierri, P; Franchitto, A; Mosesso, P; Palitti, F
      Werner's syndrome cell lines are hypersensitive to camptothecin-induced chromosomal damage

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    59. Mosesso, P; Pichierri, P; Franchitto, A; Palitti, F
      Evidence that camptothecin-induced aberrations in the G(2) phase of cell cycle of Chinese hamster ovary (CHO) cell lines is associated with transcription

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    60. Sukardiman; Darwanto, A; Tanjung, M; Darmadi, MO
      Cytotoxic mechanism of flavonoid from Temu Kunci (Kaempferia pandurata) incell culture of human mammary carcinoma

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    61. Utz, PJ; Anderson, P
      Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules

      CELL DEATH AND DIFFERENTIATION
    62. Vogelauer, M; Cioci, F; Bordi, L; Camilloni, G
      In vivo studies of the non-transcribed spacer region of rDNA in Saccharomyces cerevisiae

      FOOD TECHNOLOGY AND BIOTECHNOLOGY
    63. Fulco, RA; Costa, C; Germano, MP; Torre, EA; Viscomi, MG; Salimbeni, V; Maisano, R; Giudice, A; Costa, G
      Hepatotoxicity of camptothecin derivatives in a primary culture system of rat hepatocytes

      JOURNAL OF CHEMOTHERAPY
    64. Santos, A; Zanetta, S; Cresteil, T; Deroussent, A; Pein, F; Raymond, E; Vernillet, L; Risse, ML; Boige, V; Gouyette, A; Vassal, G
      Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans

      CLINICAL CANCER RESEARCH
    65. Moutsopoulos, NM; Routsias, JG; Vlachoyiannopoulos, PG; Tzioufas, AG; Moutsopoulos, HM
      B-cell epitopes of intracellular autoantigens: Myth and reality

      MOLECULAR MEDICINE
    66. Tan, FK; Arnett, FC
      Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon

      CURRENT OPINION IN RHEUMATOLOGY
    67. Werbovetz, KA; Bhattacharjee, AK; Brendle, JJ; Scovill, JP
      Analysis of stereoelectronic properties of camptothecin analogues in relation to biological activity

      BIOORGANIC & MEDICINAL CHEMISTRY
    68. Ferlin, MG; Gatto, B; Chiarelotto, G; Palumbo, M
      Pyrrolo-quinoline derivatives as potential antineoplastic drugs

      BIOORGANIC & MEDICINAL CHEMISTRY
    69. Uhlmann, F
      Chromosome cohesion: A polymerase for chromosome bridges

      CURRENT BIOLOGY
    70. Verweij, J; de Jonge, MJA
      Achievements and future of chemotherapy

      EUROPEAN JOURNAL OF CANCER
    71. Gornet, JM; Azoulay, D; Levi, F; Yovine, A; Misset, JL; Goldwasser, F
      Dramatic tumor response of bulky liver metastases following treatment withCPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient

      ANTI-CANCER DRUGS
    72. Boabang, P; Kurbacher, CM; Kohlhagen, H; Waida, A; Amo-Takyi, BK
      Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay

      ANTI-CANCER DRUGS
    73. Vicario, JL; Badia, D; Dominguez, E; Carrillo, L
      Stereocontrolled synthesis of 2-aryl tetralones. Application in the synthesis of B/C hexahydrobenzo[c]phenanthridine alkaloids

      TETRAHEDRON-ASYMMETRY
    74. Goossens, JF; Henichart, JP; Dassonneville, L; Facompre, M; Bailly, C
      Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    75. Maiello, E; Gebbia, V; Giuliani, F; Paoletti, G; Gebbia, N; Cigolari, S; Fortunato, S; Pedicini, T; Borsellino, N; Lopez, M; Colucci, G
      5-fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group

      ANNALS OF ONCOLOGY
    76. Sorensen, M; Jensen, PB; Herrstedt, J; Hirsch, FR; Hansen, HH
      A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer

      ANNALS OF ONCOLOGY
    77. Daigle, F; Forget, C; Martin, C; Drolet, M; Tessier, MC; Dezfulian, H; Harel, J
      Effects of global regulatory proteins and environmental conditions on fimbrial gene expression of F165(1) and F165(2) produced by Escherichia coli causing septicaemia in pigs

      RESEARCH IN MICROBIOLOGY
    78. Yanase, K; Sugimoto, Y; Tsukahara, S; Oh-hara, T; Andoh, T; Tsuruo, T
      Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma

      JAPANESE JOURNAL OF CANCER RESEARCH
    79. Enzinger, PC; Ilson, DH
      Irinotecan in esophageal cancer

      ONCOLOGY-NEW YORK
    80. Komaki, R; Janjan, NA; Ajani, JA; Lynch, PM; Fairweather, JS; Raijman, I; Blumenshein, GR; Ho, L; Pisters, PWT; Feig, BW; Walsh, GL; Pazdur, R
      Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors

      ONCOLOGY-NEW YORK
    81. de Jonge, MJA; Loos, WJ; Gelderblom, H; Planting, AST; van der Burg, MEL; Sparreboom, A; Brouwer, E; van Beurden, V; Mantel, MA; Doyle, E; Hearn, S; Ross, G; Verweij, J
      Phase I pharmacologic study of oral topotecan and intravenous cisplatin: Sequence-dependent hematologic side effects

      JOURNAL OF CLINICAL ONCOLOGY
    82. de Jonge, MJA; Sparreboom, A; Planting, AST; van der Burg, MEL; de Boer-Dennert, MM; ter Steeg, J; Jacques, C; Verweij, J
      Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    83. Vanhoefer, U; Achterrath, W; Wilke, H; Seeber, S
      Preclinical evaluation of irinotecan

      ONKOLOGIE
    84. Tam, MN; Nam, NH; Jin, GZ; Song, GY; Ahn, BZ
      Synthesis and evaluation of the antitumor activity of 2-substituted 1,4-dihydroxy-9,10-anthraquinones

      ARCHIV DER PHARMAZIE
    85. Akhtar, S; Beckman, RA; Mould, DR; Doyle, E; Fields, SZ; Wright, J
      Pretreatment with ranitidine does not reduce the bioavailability of orallyadministered topotecan

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    86. Voeller, DM; Grem, JL; Pommier, Y; Paull, K; Allegra, CJ
      Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    87. Falkner, D; Wilson, J; Fertig, N; Clawson, K; Medsger, TA; Morel, PA
      Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin)

      JOURNAL OF RHEUMATOLOGY
    88. Akimoto, S; Abe, M; Ishikawa, O
      HLA-DRB1 and DQB1 genes in Japanese patients with systemic sclerosis

      JOURNAL OF RHEUMATOLOGY
    89. Oda, T; Kayukawa, K; Hagiwara, H; Yudate, HT; Masuho, Y; Murakami, Y; Tamura, T; Muramatsu, M
      A novel TATA-binding protein-binding protein, ABT1, activates basal transcription and has a yeast homolog that is essential for growth

      MOLECULAR AND CELLULAR BIOLOGY
    90. Johnson, MA; Bryant, PE; Jones, NJ
      Isolation of camptothecin-sensitive Chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group

      MUTAGENESIS
    91. Longman, D; Johnstone, IL; Caceres, JF
      Functional characterization of SR and SR-related genes in Caenorhabditis elegans

      EMBO JOURNAL
    92. Koshiyama, M; Fujii, H; Kinezaki, M; Ohgi, S; Konishi, M; Hidetaka, N; Hayashi, M; Yoshida, M
      Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrialcarcinomas: a comparison with cisplatin

      ANTICANCER RESEARCH
    93. Song, GY; Kim, Y; Zheng, XG; You, YJ; Cho, H; Chung, JH; Sok, DE; Ahn, BZ
      Naphthazarin derivatives (IV): synthesis, inhibition of DNA topoisomerase I and cytotoxicity of 2-or 6-acyl-5,8-dimethoxy-1,4-naphahoquinones

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    94. Cesarone, CF; Scarabelli, L; Demori, I; Balocco, S; Fugassa, E
      Poly(ADP-ribose) polymerase is affected early by thyroid state during liver regeneration in rats

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    95. Taron, M; Plasencia, C; Abad, A; Martin, C; Guillot, M
      Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines

      INVESTIGATIONAL NEW DRUGS
    96. Zhou, BN; Hoch, JM; Johnson, RK; Mattern, MR; Eng, WK; Ma, J; Hecht, SM; Newman, DJ; Kingston, DGI
      Use of COMPARE analysis to discover new natural product drugs: Isolation of camptothecin and 9-methoxycamptothecin from a new source

      JOURNAL OF NATURAL PRODUCTS
    97. Makinsky, AA; Kritzyn, AM; Uljanova, EA; Zakharova, OD; Nevinsky, GA
      Polymethylene derivatives of pyrimidine nucleic bases bearing omega-functional groups

      BIOORGANICHESKAYA KHIMIYA
    98. Rose, PG; Gordon, NH; Fusco, N; Fluellen, L; Rodriguez, M; Ingalls, ST; Hoppel, CL
      A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    99. Coleman, LW; Perkins, SL; Bronstein, IB; Holden, JA
      Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in testicular seminomas

      HUMAN PATHOLOGY
    100. Gupta, D; Bronstein, IB; Holden, JA
      Expression of DNA topoisomerase I in neoplasms of the kidney: Correlation with histological grade, proliferation, and patient survival

      HUMAN PATHOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 05:51:28